We are live on ! Find out more
APLT icon

Applied Therapeutics

Delisted

APLT was delisted on the 2nd of February, 2026.

53 hedge funds and large institutions have $25.6M invested in Applied Therapeutics in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 20 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

528% more capital inflows, than outflows

Capital inflows: $27.6M | Capital outflows: $4.4M

10.74% more ownership

Funds ownership: 47.09% → 57.83% (+11%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

13% less call options, than puts

Call options by funds: $14K | Put options by funds: $16K

24% less funds holding

Funds holding: 70 → 53 (-17)

35% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 20

62% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 26

Holders
53
Holders Change
-17
Holders Change %
-24.29%
% of All Funds
0.89%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
13
Reduced
20
Closed
26
Calls
$14​K
Puts
$16​K
Net Calls
-⁠$2​K
Net Calls Change
+$33​K

APLT Hedge Fund Activity: Q2 2022 in Review

53 of the 5,961 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q2 2022, worth a combined $25.6M — down 1.6% from $26M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of APLT and 10 opened new positions — a net loss of 16 holders — while 20 trimmed existing stakes and 13 added.

The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $7.13M. The largest seller was BlackRock, cutting an estimated $1.43M.

  • 53 institutional investors held Applied Therapeutics (APLT) as of Q2 2022, down from 70 in Q1 2022.
  • Funds reported $25.6M of Applied Therapeutics stock for Q2 2022, down 1.6% quarter-over-quarter.
  • 10 funds opened new Applied Therapeutics positions in Q2 2022 and 26 closed out, a net change of -16 holders.
  • The largest Applied Therapeutics buyer in Q2 2022 was Alyeska Investment Group, an estimated $7.13M added.
  • The largest Applied Therapeutics seller in Q2 2022 was BlackRock, an estimated $1.43M sold.

Based on aggregated 13F filings for Q2 2022.